AT356814B - Verfahren zur herstellung von neuen clavulan- saeurederivaten - Google Patents

Verfahren zur herstellung von neuen clavulan- saeurederivaten

Info

Publication number
AT356814B
AT356814B AT395477A AT395477A AT356814B AT 356814 B AT356814 B AT 356814B AT 395477 A AT395477 A AT 395477A AT 395477 A AT395477 A AT 395477A AT 356814 B AT356814 B AT 356814B
Authority
AT
Austria
Prior art keywords
acid derivatives
clavulanic acid
producing new
producing
new
Prior art date
Application number
AT395477A
Other languages
English (en)
Other versions
ATA395477A (de
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Priority to AT612677A priority Critical patent/AT352099B/de
Publication of ATA395477A publication Critical patent/ATA395477A/de
Application granted granted Critical
Publication of AT356814B publication Critical patent/AT356814B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT395477A 1975-06-02 1977-06-03 Verfahren zur herstellung von neuen clavulan- saeurederivaten AT356814B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT612677A AT352099B (de) 1975-06-02 1977-08-24 Verfahren zur herstellung von neuen, stereoisomeren, n-substituierten 2-aminocyclohexan- oder -pentan-carbonsaeuren und deren amiden sowie von deren saeure- additionssalzen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB23268/76A GB1585124A (en) 1976-06-04 1976-06-04 Clavulanic acid derivatives

Publications (2)

Publication Number Publication Date
ATA395477A ATA395477A (de) 1979-10-15
AT356814B true AT356814B (de) 1980-05-27

Family

ID=10192928

Family Applications (1)

Application Number Title Priority Date Filing Date
AT395477A AT356814B (de) 1975-06-02 1977-06-03 Verfahren zur herstellung von neuen clavulan- saeurederivaten

Country Status (15)

Country Link
JP (1) JPS5321193A (de)
AT (1) AT356814B (de)
AU (1) AU517897B2 (de)
BE (1) BE855375A (de)
CH (1) CH628055A5 (de)
DE (1) DE2725203A1 (de)
DK (1) DK247877A (de)
ES (2) ES459479A1 (de)
FI (1) FI771772A (de)
FR (1) FR2353556A1 (de)
GB (1) GB1585124A (de)
IL (1) IL52244A0 (de)
NL (1) NL7706119A (de)
SE (1) SE7706518L (de)
ZA (1) ZA773348B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1604822A (en) * 1977-04-22 1981-12-16 Beecham Group Ltd N-monosubstituted-9-amino-9-deoxyclavulanic acid derivative
FR2388814A1 (fr) * 1977-04-27 1978-11-24 Beecham Group Ltd Nouveaux derives de l'acide clavulanique, utilisables comme medicament
JPS54117459A (en) * 1978-01-20 1979-09-12 Glaxo Group Ltd Novel lactam compound
EP0028083B1 (de) * 1979-10-26 1984-02-08 Beecham Group Plc Clavulansäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
NZ199061A (en) * 1980-12-09 1984-10-19 Beecham Group Ltd 9-(n-tetrazolyl)-deoxyclavulanic acids,salts,esters,and pharmaceutical compositions
EP0068609A1 (de) * 1981-06-11 1983-01-05 Beecham Group Plc Clavulansäure Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung
GB8521516D0 (en) * 1985-08-29 1985-10-02 Beecham Group Plc Compounds
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds

Also Published As

Publication number Publication date
ES470333A1 (es) 1979-01-01
FR2353556A1 (fr) 1977-12-30
ES459479A1 (es) 1978-11-16
CH628055A5 (en) 1982-02-15
DE2725203A1 (de) 1977-12-22
DK247877A (da) 1977-12-05
SE7706518L (sv) 1978-01-23
NL7706119A (nl) 1977-12-06
FR2353556B1 (de) 1980-04-04
BE855375A (fr) 1977-12-05
AU2580477A (en) 1978-12-07
AU517897B2 (en) 1981-09-03
ZA773348B (en) 1978-06-28
JPS6135994B2 (de) 1986-08-15
JPS5321193A (en) 1978-02-27
FI771772A (de) 1977-12-05
ATA395477A (de) 1979-10-15
IL52244A0 (en) 1977-08-31
GB1585124A (en) 1981-02-25

Similar Documents

Publication Publication Date Title
AT358557B (de) Verfahren zur herstellung von neuen substi- tuierten 3-phenoxy-phenylthioalkancarbonsaeure- derivaten
AT367430B (de) Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten
AT360005B (de) Verfahren zur herstellung von neuen sulfonyl- benzimidazolderivaten
AT369005B (de) Verfahren zur herstellung von neuen cephalosporan-saeurederivaten
AT362085B (de) Verfahren zur herstellung von neuen 16- -dehydroandrostan-derivaten
AT344163B (de) Verfahren zur herstellung von neuen oxadiazolinon-derivaten
AT360006B (de) Verfahren zur herstellung von neuen thiazolinylbenzimidazolderivaten
AT359994B (de) Verfahren zur herstellung von neuen benzoe- saeurederivaten und acylophenonen
AT347453B (de) Verfahren zur herstellung von neuen 5-phenyl- oxazolidinon-2-derivaten
AT352120B (de) Verfahren zur herstellung von neuen benzoxocin- derivaten
AT356814B (de) Verfahren zur herstellung von neuen clavulan- saeurederivaten
AT357693B (de) Verfahren zur herstellung von neuen ergolen- -derivaten
AT356655B (de) Verfahren zur herstellung von neuen benzodia- zepinderivaten
AT363181B (de) Verfahren zur herstellung von neuen clavulansaeurederivaten
AT365170B (de) Verfahren zur herstellung von neuen 13-thiaprostansaeurederivaten
AT347937B (de) Verfahren zur herstellung von neuen sulfonylbenzimidazol-derivaten
AT370106B (de) Verfahren zur herstellung von neuen penicillansaeurederivaten
AT361928B (de) Verfahren zur herstellung von neuen chinolonderivaten
AT363462B (de) Verfahren zur herstellung von neuen arylalkansaeurederivaten
AT364847B (de) Verfahren zur herstellung von neuen clavulansaeurederivaten
ATA259780A (de) Verfahren zur herstellung von neuen 6-betasubstituierten penicillansaeurederivaten
AT362349B (de) Verfahren zur herstellung von neuen 3-amino-2- -hydroxypropoxyaryl-derivaten
ATA564679A (de) Verfahren zur herstellung von neuen hydroxylamino-hydrocarbylphosphonsaeurederivaten
ATA5381A (de) Verfahren zur herstellung von neuen 13-thiaprostansaeurederivaten
AT347962B (de) Verfahren zur herstellung von neuen thienothiazinderivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee